Download | < Back |
14 Jun 2018 | |
With reference to the captioned subject, this is to inform the exchange that the Company has received US Food & Drug Administration (USFDA) Approval for Doxycycline Hyclate Capsules USP, 50 mg and 100 mg. Please find enclosed herewith our press release.<BR> <BR> We request you to kindly take the same on record.<BR> | |
View all announcements for ALEMBIC PHARMACEUTICALS LTD. | Source: BSE India |